(Q37706585)

22 August 2017

1 reference

title

The epidemiology of meningococcal disease and the impact of vaccines (English)

1 reference

22 August 2017

1 reference

meningococcal disease

1 reference

2

Andrew J Pollard

1 reference

22 August 2017

Ameneh Khatami

1

1 reference

22 August 2017

publication date

1 March 2010

1 reference

Expert Review of Vaccines

22 August 2017

published in

1 reference

22 August 2017

volume

9

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

285-298

1 reference

Prospects for vaccine prevention of meningococcal infection

22 August 2017

cites work

1 reference

21 January 2018

Meningococcal disease

1 reference

The immunopathogenesis of meningococcal disease

21 January 2018

1 reference

Meningococcal vaccine in travelers

21 January 2018

1 reference

Meningococcal disease and travel

21 January 2018

1 reference

Recent trends in meningococcal epidemiology and current vaccine recommendations

21 January 2018

1 reference

Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines

21 January 2018

1 reference

Multi-locus sequence typing: a tool for global epidemiology

21 January 2018

1 reference

Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway

21 January 2018

1 reference

Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

21 January 2018

1 reference

Multilocus sequence typing for global surveillance of meningococcal disease.

21 January 2018

1 reference

Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes

21 January 2018

1 reference

Lessons from meningococcal carriage studies

21 January 2018

1 reference

Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study

21 January 2018

1 reference

Human immunity to the meningococcus. II. Development of natural immunity

21 January 2018

1 reference

Characterization of humoral and cellular immune responses elicited by meningococcal carriage.

21 January 2018

1 reference

Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students.

21 January 2018

1 reference

Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.

21 January 2018

1 reference

Mortality in severe meningococcal disease

21 January 2018

1 reference

Mortality in meningococcal disease

21 January 2018

1 reference

Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

21 January 2018

1 reference

Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000.

21 January 2018

1 reference

Host genetic determinants of Neisseria meningitidis infections.

21 January 2018

1 reference

Influenza A and meningococcal disease

21 January 2018

1 reference

Risk factors for meningococcal disease in college students

21 January 2018

1 reference

Meningitis epidemics in Africa: a brief overview

21 January 2018

1 reference

Invasive meningococcal disease epidemiology and control measures: a framework for evaluation

21 January 2018

1 reference

Opportunities for control of meningococcal disease in the United States

21 January 2018

1 reference

Conquering the meningococcus

21 January 2018

1 reference

A surveillance network for meningococcal disease in Europe.

21 January 2018

1 reference

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

21 January 2018

1 reference

Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19).

21 January 2018

1 reference

Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines

21 January 2018

1 reference

A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000.

21 January 2018

1 reference

Epidemiology of meningococcal disease in Australia

21 January 2018

1 reference

W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina.

21 January 2018

1 reference

Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread

21 January 2018

1 reference

Manson Lecture. Meningococcal meningitis in Africa

21 January 2018

1 reference

Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000

21 January 2018

1 reference

Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana

21 January 2018

1 reference

Genetic characteristics of serogroup A meningococci circulating in China, 1956-2005.

21 January 2018

1 reference

Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, China

21 January 2018

1 reference

Group A meningococcal carriage in travelers returning from Saudi Arabia

21 January 2018

1 reference

Serogroup W135 meningococcal disease in Hajj pilgrims.

21 January 2018

1 reference

Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers.

21 January 2018

1 reference

The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis

21 January 2018

1 reference

Strong positive selection and recombination drive the antigenic variation of the PilE protein of the human pathogen Neisseria meningitidis

21 January 2018

1 reference

Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.

21 January 2018

1 reference

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

21 January 2018

1 reference

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

21 January 2018

1 reference

Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.

21 January 2018

1 reference

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

21 January 2018

1 reference

Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients

21 January 2018

1 reference

A review of vaccine research and development: meningococcal disease

21 January 2018

1 reference

CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.

21 January 2018

1 reference

Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine

21 January 2018

1 reference

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine

21 January 2018

1 reference

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

21 January 2018

1 reference

Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents

21 January 2018

1 reference

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

21 January 2018

1 reference

Changing epidemiology of bacterial meningitis among adults in England and Wales 1991-2002

21 January 2018

1 reference

Prevention of invasive meningococcal disease in the United States

21 January 2018

1 reference

Meningococcal polysaccharide-protein conjugate vaccines.

21 January 2018

1 reference

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

21 January 2018

1 reference

A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.

21 January 2018

1 reference

A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.

21 January 2018

1 reference

A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana

21 January 2018

1 reference

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa

21 January 2018

1 reference

Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers.

21 January 2018

1 reference

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

21 January 2018

1 reference

A prospective study of the effectiveness of the New Zealand meningococcal B vaccine.

21 January 2018

1 reference

Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years

21 January 2018

1 reference

Prevention of meningococcal serogroup B infections in children: a protein-based vaccine induces immunologic memory.

21 January 2018

1 reference

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

21 January 2018

1 reference

Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines

21 January 2018

1 reference

Immunogenicity and safety of three doses of a bivalent (B:4:p1.19,15 and B:4:p1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents

21 January 2018

1 reference

Meningococcal protein antigens and vaccines

21 January 2018

1 reference

Opacity-associated adhesin repertoire in hyperinvasive Neisseria meningitidis

21 January 2018

1 reference

Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine

21 January 2018

1 reference

Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis

21 January 2018

1 reference

Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine

21 January 2018

1 reference

NadA, a novel vaccine candidate of Neisseria meningitidis

21 January 2018

1 reference

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus

21 January 2018

1 reference

Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.

21 January 2018

1 reference

A universal vaccine for serogroup B meningococcus

21 January 2018

1 reference

Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2

21 January 2018

1 reference

Genetic Analysis of Meningococci Carried by Children and Young Adults

21 January 2018

1 reference

Antigenic Shift and Increased Incidence of Meningococcal Disease

21 January 2018

1 reference

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

21 January 2018

1 reference

Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults

21 January 2018

1 reference

Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec

21 January 2018

1 reference

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.10.3

1 reference

22 August 2017

1 reference